CD37 Blocking Peptide – The purity is >90%,tested by HPLC and MS. Purity

Name: CD37 Blocking Peptide; The purity is >90%,tested by HPLC and MS. Purity; MyBioSource
Brand: MyBioSource
SKU: MBS9619935
Price: 460 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS9619935

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the… More details

$460 / 1 mg +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

CD37, Blocking Peptide

Full Product Name

CD37 Blocking Peptide

Product Gene Name

CD37 blocking peptide

Product Synonym Names

CD 37; Cd37; CD37 antigen; CD37 molecule; CD37_HUMAN; Cell differentiation antigen 37; GP52 40; Leukocyte antigen CD37; Leukocyte surface antigen CD37; MGC120234; Tetraspanin 26; Tetraspanin-26; Tetraspanin26; TSPAN 26; Tspan-26; TSPAN26

Form/Format

Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.

Purity/Purification

The purity is >90%,tested by HPLC and MS.

Preparation and Storage

Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C.

Antibody/Peptide Pairs

CD37 peptide (MBS9619935) is used for blocking the activity of CD37 antibody (MBS9602482)

Molecular Weight

22,563 Da

OMIM

151523

Supply Chain Verification

Manufactured in a lab with traceable raw materials manufactured on site. Coordinated product portfolio of antibodies, pairs, conjugates, recombinant proteins, and immunoassay materials available, please inquire.

Notes

For phospho antibody, we provide phospho peptide (0.5mg) and non-phospho peptide (0.5mg)

ISO Certification

Manufactured in an ISO 9001:2015 Certified Laboratory.

Applications Tested/Suitable for CD37 blocking peptide

Blocking/Control

Other Notes

Small volumes of CD37 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for CD37 purchase

MBS9619935 is a blocking peptide targeting CD37.

Additional Details

NCBI/Uniprot data below describe general gene information for CD37. It may not necessarily be applicable to this product.

NCBI GI #

91807110

NCBI GeneID

951

NCBI Accession #

NP_001035120.1

UniProt Primary Accession #

P11049

UniProt Secondary Accession #

Q3KPF9; B4DVC1

UniProt Related Accession #

P11049

GenBank Nucleotide #

NM_001040031.1

NCBI Official Full Name

leukocyte antigen CD37 isoform B

NCBI Official Synonym Full Names

CD37 molecule

NCBI Official Symbol

CD37

NCBI Official Synonym Symbols

GP52-40; TSPAN26

UniProt Protein Name

Leukocyte antigen CD37

UniProt Synonym Protein Names

Tetraspanin-26; Tspan-26; CD_antigen: CD37

Protein Family

Leukocyte antigen

UniProt Gene Name

CD37

UniProt Synonym Gene Names

TSPAN26; Tspan-26

UniProt Entry Name

CD37_HUMAN

NCBI Protein Information

leukocyte antigen CD37

UniProt Comments for CD37

CD37: is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins. It may play a role in T-cell-B-cell interactions. Alternate splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]

Protein type: Membrane protein, integral; Membrane protein, multi-pass

Chromosomal Location of Human Ortholog: 19q13.3

Cellular Component: immunological synapse; integral to plasma membrane; membrane

Molecular Function: protein binding

Biological Process: cell surface receptor linked signal transduction

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Products associated with CD37 blocking peptide

Reference Product	PubMed Publications
CD22 blocking peptide	>42 publications with CD37 and CD22
SYK blocking peptide	>3 publications with CD37 and SYK
UPK1B blocking peptide	>2 publications with CD37 and UPK1B
LYN blocking peptide	>2 publications with CD37 and LYN

Pathways associated with CD37 blocking peptide

Products by Pathway	Pathway Diagram
Hematopoietic Cell Lineage Pathway antibodies	Hematopoietic Cell Lineage Pathway Diagram
Hematopoietic Cell Lineage Pathway antibodies	Hematopoietic Cell Lineage Pathway Diagram

Diseases associated with CD37 blocking peptide

Disease Name	Pubmed Publications
Immune System Diseases Antibodies	>105 publications with CD37 and Immune System Diseases
Cardiovascular Diseases Antibodies	>9 publications with CD37 and Cardiovascular Diseases
Inflammation Antibodies	>9 publications with CD37 and Inflammation
Necrosis Antibodies	>6 publications with CD37 and Necrosis
Carcinoma Antibodies	>6 publications with CD37 and Carcinoma
Disease Models, Animal Antibodies	>5 publications with CD37 and Disease Models, Animal
Skin Neoplasms Antibodies	>4 publications with CD37 and Skin Neoplasms
Breast Neoplasms Antibodies	>2 publications with CD37 and Breast Neoplasms
Kidney Diseases Antibodies	>2 publications with CD37 and Kidney Diseases
Edema Antibodies	>2 publications with CD37 and Edema

Organs/Tissues associated with CD37 blocking peptide

Organ/Tissue Name	Pubmed Publications
Blood Antibodies	>126 publications with CD37 and Blood
Bone Antibodies	>31 publications with CD37 and Bone
Bone Marrow Antibodies	>29 publications with CD37 and Bone Marrow
Lymph Node Antibodies	>20 publications with CD37 and Lymph Node
Lymph Antibodies	>18 publications with CD37 and Lymph
Spleen Antibodies	>12 publications with CD37 and Spleen
Thymus Antibodies	>8 publications with CD37 and Thymus
Lung Antibodies	>4 publications with CD37 and Lung
Pharynx Antibodies	>4 publications with CD37 and Pharynx
Vascular Antibodies	>4 publications with CD37 and Vascular